PF-08634404 monotherapy or in combination w/Enfortumab Vedotin in patients with urothelial cancer

An Interventional Phase 1b/2, Open-Label Study to Investigate the Safety, Antitumor Activity, and Pharmacokinetics of PF-08634404 Monotherapy or in Combination With Enfortumab Vedotin in Adult Participants With Locally Advanced or Metastatic Urothelial Cancer

Disease Types: Urothelial

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

An Interventional Phase 1b/2, Open-Label Study to Investigate the Safety, Antitumor Activity, and Pharmacokinetics of PF-08634404 Monotherapy or in Combination With Enfortumab Vedotin in Adult Participants With Locally Advanced or Metastatic Urothelial Cancer

For More Information:

https://clinicaltrials.gov/study/NCT07421700?term=PF-08634404%20&viewType=Card&cond=Urothelial%20Carcinoma&rank=1